Pulike Biological Engineering (603566) — Strategic Asset Allocation Index
Pulike Biological Engineering (603566) has a Strategic Asset Allocation Index of 37.6% as of June 2023. Strategic assets (PP&E of CN¥1.05 Billion plus long-term investments of CN¥-) total CN¥1.05 Billion, measured against net assets of CN¥2.79 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Pulike Biological Engineering Strategic Asset Allocation Index (2012–2021)
This chart shows how Pulike Biological Engineering's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2021. As of June 2023, the index stands at 37.6%, representing strategic assets of CN¥1.05 Billion against net assets of CN¥2.79 Billion CNY. Explore 603566 cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Pulike Biological Engineering (2012–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Pulike Biological Engineering from 2012 to 2021, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 603566 stock market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 36.2% | CN¥651.60 Million | CN¥651.60 Million | CN¥- | CN¥1.80 Billion | ▲ +9.0 pp |
| 2020 | 27.2% | CN¥465.61 Million | CN¥465.61 Million | CN¥- | CN¥1.71 Billion | ▲ +3.4 pp |
| 2019 | 23.8% | CN¥395.37 Million | CN¥395.37 Million | CN¥- | CN¥1.66 Billion | ▼ -16.4 pp |
| 2018 | 40.2% | CN¥657.54 Million | CN¥367.36 Million | CN¥290.17 Million | CN¥1.64 Billion | ▲ +12.9 pp |
| 2017 | 27.3% | CN¥427.82 Million | CN¥369.28 Million | CN¥58.53 Million | CN¥1.57 Billion | ▲ +1.9 pp |
| 2016 | 25.4% | CN¥375.85 Million | CN¥333.52 Million | CN¥42.33 Million | CN¥1.48 Billion | ▲ +3.1 pp |
| 2015 | 22.2% | CN¥297.41 Million | CN¥290.73 Million | CN¥6.68 Million | CN¥1.34 Billion | ▼ -20.8 pp |
| 2014 | 43.0% | CN¥294.17 Million | CN¥294.17 Million | CN¥- | CN¥683.59 Million | ▼ -5.5 pp |
| 2013 | 48.6% | CN¥293.09 Million | CN¥293.09 Million | CN¥- | CN¥603.33 Million | ▲ +7.3 pp |
| 2012 | 41.3% | CN¥181.85 Million | CN¥181.85 Million | CN¥- | CN¥440.47 Million | — |